Haemonetics Corp. (HAE)
63.76
-0.91
(-1.41%)
USD |
NYSE |
Mar 05, 15:32
Haemonetics EPS Diluted (Quarterly) : 0.9522 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 1.030 |
| Boston Scientific Corp. | 0.4493 |
| DexCom, Inc. | 0.6761 |
| Masimo Corp. | 1.311 |
| Stryker Corp. | 2.197 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 44.74M |
| Revenue (Quarterly) | 338.97M |
| Total Expenses (Quarterly) | 294.23M |
| Enterprise Value | 3.867B |
| Gross Profit Margin (Quarterly) | 56.47% |
| Profit Margin (Quarterly) | 13.20% |
| Earnings Yield | 5.71% |
| Operating Earnings Yield | 7.93% |
| Normalized Earnings Yield | 5.719 |